AI Article Synopsis

  • The study investigates the genetic causes of autosomal dominant isolated hypoparathyroidism in two multigenerational families with 14 affected members.
  • Whole exome sequencing and minigene splicing assays were used to identify mutations, finding splice-altering mutations in the TBX1 gene in both families.
  • The findings suggest that TBX1 mutations contribute to isolated hypoparathyroidism and enhance understanding of the genetic factors involved in this condition.

Article Abstract

Context: Most cases of autosomal dominant isolated hypoparathyroidism are caused by gain-of-function mutations in CASR or GNA11 or dominant negative mutations in GCM2 or PTH.

Objective: To identify the genetic etiology for dominantly transmitted isolated hypoparathyroidism in two multigenerational families with 14 affected family members.

Methods: We performed whole exome sequencing of DNA from two families and examined the consequences of mutations by minigene splicing assay.

Results: We discovered disease-causing mutations in both families. A splice-altering mutation in TBX1 (c.1009+1G>C) leading to skipping of exon 8 (101 bp) was identified in 10 affected family members and five unaffected subjects of family A, indicating reduced penetrance for this point mutation. In a second family from France (family B), we identified another splice-altering mutation (c.1009+2T>C) adjacent to the mutation identified in family A that results in skipping of the same exon; two subjects in family B had isolated hypoparathyroidism, whereas a third subject manifested the clinical triad of the 22q11.2 deletion syndrome, indicative of variable expressivity.

Conclusions: We report evidence that heterozygous TBX1 mutations can cause isolated hypoparathyroidism. This study adds knowledge to the increasingly expanding list of causative and candidate genes in isolated hypoparathyroidism.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194809PMC
http://dx.doi.org/10.1210/jc.2018-01260DOI Listing

Publication Analysis

Top Keywords

isolated hypoparathyroidism
24
splice-altering mutation
8
skipping exon
8
identified family
8
subjects family
8
family
7
isolated
6
hypoparathyroidism
6
mutations
5
heterozygous mutations
4

Similar Publications

Purpose: This study aims to evaluate the etiology, clinical presentation, and management of pediatric hypoparathyroidism in a tertiary center.

Methods: A retrospective review was conducted on pediatric patients diagnosed with hypoparathyroidism at the Pediatric Endocrinology Clinic from March 2021 to June 2023. Data on demographic characteristics, presenting symptoms, laboratory findings, genetic analyses, and treatment outcomes were collected.

View Article and Find Full Text PDF

Three Siblings With Familial Isolated Hypoparathyroidism: A Diagnostic Journey From to Novel Variant.

JCEM Case Rep

November 2024

Division of Pediatric Endocrinology, UCLA Children's Discovery and Innovation Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.

We report a patient who initially presented at 4 days old with hypocalcemia, hypoparathyroidism, and elevated phosphorous level. Treatment was initiated with calcitriol, calcium carbonate (CaCO), vitamin D, and low phosphorous formula. Family history was positive for an activating calcium sensing receptor () variant (R990G) identified previously in 2 older siblings who were treated with CaCO and calcitriol.

View Article and Find Full Text PDF
Article Synopsis
  • This report investigates a family with familial isolated hypoparathyroidism (FIH), highlighting a specific mutation that leads to high levels of functionally inactive parathyroid hormone (PTH) in a 34-year-old woman and her siblings.* -
  • The siblings were diagnosed with pseudohypoparathyroidism type 1b, characterized by chronic low calcium levels and elevated PTH, but without the typical features of related disorders.* -
  • Treatment with teriparatide, a recombinant human PTH, successfully normalized calcium levels and improved wellbeing for the patient, indicating that inactive variants of PTH can lead to complex hypocalcemia cases.*
View Article and Find Full Text PDF
Article Synopsis
  • The researchers developed a new method called CRISPR/Cas9-targeted long-read sequencing (CTLR-Seq) to analyze complex regions of the human genome that traditional sequencing couldn't handle, especially large segmental duplications (SegDups) and their related rearrangements.
  • CTLR-Seq uses a combination of Cas9 cutting and specialized gel techniques to isolate large genomic regions, enabling high-quality long-read sequencing for complete assembly of these previously elusive sequences.
  • This method was applied to the 22q11.2 Deletion Syndrome, allowing the team to map out significant genomic rearrangements with high variability linked to transposons and discover cell-type-specific interactions and DNA methylation patterns in patient-derived cells.
View Article and Find Full Text PDF

Objectives: This retrospective study aims to investigate the evolution and clinical course of psychotic disorders from three large international cohorts of individuals with 22q11.2 deletion syndrome (22q11.2DS) (Tel Aviv, Philadelphia, and Geneva).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!